PPARα Activation Overcomes Fibroinflammatory Anti-PD-1 Resistance in Liver Cancer via GSDME Pyroptosis
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
A new early-stage clinical study reports that targeting tumor metabolism and immune recognition may offer a workable strategy for patients ...
In a groundbreaking study published in the prestigious journal Cell on June 22, 2026, researchers from The University of Texas ...
In a groundbreaking advancement poised to reshape the landscape of multiple myeloma treatment, researchers from the Icahn School of Medicine ...
At the forefront of cancer innovation, researchers from Memorial Sloan Kettering Cancer Center (MSK) showcased groundbreaking advancements at the 2026 ...
In a groundbreaking study published in the prestigious journal Immunity, researchers from Oregon Health & Science University (OHSU) have shed ...
In a groundbreaking study poised to reshape therapeutic strategies against colorectal cancer, researchers have uncovered a pivotal role of circulating ...
In a groundbreaking development poised to redefine cancer immunotherapy, researchers at the University of Liège, led by Pierre Close, have ...
In the relentless pursuit of more effective cancer therapies, researchers have turned their attention to an unlikely ally residing within ...
A groundbreaking study published in the journal Science has unveiled compelling evidence that the gut microbiome—the diverse community of microorganisms ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine